Cargando…
Beta-Blockers and Cancer: Where Are We?
Cancer is one of the leading causes of death worldwide. After diagnosis, cancer treatment may involve radiotherapy, chemotherapy, and surgery. Several of the approaches used to treat cancer also attack normal cells and, thus, there is the need for more effective treatments that decrease the toxicity...
Autores principales: | Peixoto, Rita, Pereira, Maria de Lourdes, Oliveira, Miguel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7345088/ https://www.ncbi.nlm.nih.gov/pubmed/32466499 http://dx.doi.org/10.3390/ph13060105 |
Ejemplares similares
-
Overview of Antifungal Drugs against Paracoccidioidomycosis: How Do We Start, Where Are We, and Where Are We Going?
por: do Carmo Silva, Lívia, et al.
Publicado: (2020) -
Twenty Years after Bovine Vaccinia in Brazil: Where We Are and Where Are We Going?
por: José da Silva Domingos, Iago, et al.
Publicado: (2021) -
Lifestyle Factors in Cancer Survivorship: Where We Are and Where We Are Headed
por: Vijayvergia, Namrata, et al.
Publicado: (2015) -
NDM-beta-lactamase-1: Where do we stand?
por: Bose, Protiti, et al.
Publicado: (2022) -
Cytokine removal in human septic shock: Where are we and where are we going?
por: Honore, Patrick M., et al.
Publicado: (2019)